Aurobindo Pharma submits copy of press release

15 Mar 2016 Evaluate

Aurobindo Pharma has submitted a copy of press release dated March 15, 2016 titled ‘Aurobindo Pharma receives USFDA Approval for Ibandronate Sodium Tablets’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1140.30 -26.90 (-2.30%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×